(Q46789125)

25 December 2017

title

DA-6034, a derivative of flavonoid, prevents and ameliorates dextran sulfate sodium-induced colitis and inhibits colon carcinogenesis (English)

1 reference

25 December 2017

1 reference

1 reference

Su Youn Nam

1

0 references

Nayoung Kim

5

object named as

Nayoung Kim

1 reference

25 December 2017

6

Hyun Chae Jung

1 reference

25 December 2017

Jung Mogg Kim

3

object named as

Jung Mogg Kim

1 reference

25 December 2017

Jong Yeul Lee

4

object named as

Jong Yeul Lee

1 reference

25 December 2017

author name string

Joo Sung Kim

2

1 reference

25 December 2017

In Sung Song

7

1 reference

25 December 2017

publication date

1 February 2008

1 reference

25 December 2017

Experimental Biology and Medicine

published in

1 reference

25 December 2017

volume

233

1 reference

25 December 2017

issue

2

1 reference

25 December 2017

page(s)

180-191

1 reference

25 December 2017

Cancer risk in patients with inflammatory bowel disease

cites work

1 reference

https://api.crossref.org/works/10.3181%2F0707-RM-186

The risk of colorectal cancer in ulcerative colitis: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.3181%2F0707-RM-186

Cancer prevention in inflammatory bowel disease and the chemoprophylactic potential of 5-aminosalicylic acid

21 January 2018

1 reference

https://api.crossref.org/works/10.3181%2F0707-RM-186

5-Aminosalicylate use and colorectal cancer risk in inflammatory bowel disease: a large epidemiological study

21 January 2018

1 reference

https://api.crossref.org/works/10.3181%2F0707-RM-186

Review article: the data supporting a role for aminosalicylates in the chemoprevention of colorectal cancer in patients with inflammatory bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3181%2F0707-RM-186

Severity of inflammation is a risk factor for colorectal neoplasia in ulcerative colitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.3181%2F0707-RM-186

Cell proliferation in carcinogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.3181%2F0707-RM-186

21 January 2018

The Hallmarks of Cancer

1 reference

https://api.crossref.org/works/10.3181%2F0707-RM-186

NF-kappaB signaling proteins as therapeutic targets for inflammatory bowel diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.3181%2F0707-RM-186

Role of NF-kappaB in immune and inflammatory responses in the gut.

21 January 2018

1 reference

https://api.crossref.org/works/10.3181%2F0707-RM-186

To be, or not to be: NF-kappaB is the answer--role of Rel/NF-kappaB in the regulation of apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.3181%2F0707-RM-186

IKKbeta links inflammation and tumorigenesis in a mouse model of colitis-associated cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.3181%2F0707-RM-186

Suppression of intestinal polyposis in Apc delta716 knockout mice by inhibition of cyclooxygenase 2 (COX-2)

21 January 2018

1 reference

https://api.crossref.org/works/10.3181%2F0707-RM-186

Suppressive effects of nimesulide, a selective inhibitor of cyclooxygenase-2, on azoxymethane-induced colon carcinogenesis in mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.3181%2F0707-RM-186

Suppression of colitis-related mouse colon carcinogenesis by a COX-2 inhibitor and PPAR ligands

21 January 2018

1 reference

https://api.crossref.org/works/10.3181%2F0707-RM-186

The effect of celecoxib, a cyclooxygenase-2 inhibitor, in familial adenomatous polyposis

21 January 2018

1 reference

https://api.crossref.org/works/10.3181%2F0707-RM-186

Cyclooxygenase 2 is induced in colonic epithelial cells in inflammatory bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3181%2F0707-RM-186

The role of prostaglandins and other eicosanoids in the gastrointestinal tract

21 January 2018

1 reference

https://api.crossref.org/works/10.3181%2F0707-RM-186

Flavonoids, a class of natural products of high pharmacological potency

21 January 2018

1 reference

https://api.crossref.org/works/10.3181%2F0707-RM-186

Biological properties of citrus flavonoids pertaining to cancer and inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.3181%2F0707-RM-186

Eupatilin, a pharmacologically active flavone derived from Artemisia plants, induces apoptosis in human gastric cancer (AGS) cells

21 January 2018

1 reference

https://api.crossref.org/works/10.3181%2F0707-RM-186

Pharmacokinetics of DA-6034, an agent for inflammatory bowel disease, in rats and dogs: Contribution of intestinal first-pass effect to low bioavailability in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.3181%2F0707-RM-186

Chronic experimental colitis induced by dextran sulphate sodium (DSS) is characterized by Th1 and Th2 cytokines

21 January 2018

1 reference

https://api.crossref.org/works/10.3181%2F0707-RM-186

Pharmacokinetics of 7-carboxymethyloxy-3',4',5-trimethoxy flavone (DA-6034), a derivative of flavonoid, in mouse and rat models of chemically-induced inflammatory bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3181%2F0707-RM-186

Combined oral and enema treatment with Pentasa (mesalazine) is superior to oral therapy alone in patients with extensive mild/moderate active ulcerative colitis: a randomised, double blind, placebo controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.3181%2F0707-RM-186

Oxidative stress and ulcerative colitis-associated carcinogenesis: studies in humans and animal models

21 January 2018

1 reference

https://api.crossref.org/works/10.3181%2F0707-RM-186

Suppression of NF-kappaB activity by sulfasalazine is mediated by direct inhibition of IkappaB kinases alpha and beta

21 January 2018

1 reference

https://api.crossref.org/works/10.3181%2F0707-RM-186

Risk factors for colorectal cancer in patients with ulcerative colitis: A case-control study

21 January 2018

1 reference

https://api.crossref.org/works/10.3181%2F0707-RM-186

21 January 2018

Identifiers

DOI

10.3181/0707-RM-186

1 reference

25 December 2017

PubMed ID

18222973

1 reference

25 December 2017